Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (262)	3/6/2015 6:05:38 PM
From: BulbaMan	Read Replies (1) \| Respond to of 407

3/6/15 Contest update Was the $108.30 I shelled out for some AbbVie Synthroid last week the final few bucks AbbVie needed for their Pharmacyclics $21 billion buyout? I guess we’ll never know for sure. Meanwhile the week ended on one of those “good news is bad news” Fridays, with a better than expected employment report bashing bonds and stocks and taking back some of the PCYC biotech bump. Still, at Friday’s close, the Contest median was up a very impressive 20.41% YTD (vs. up 16.92% YTD a week ago), while the Nasdaq Biotech Index was up 12.78% YTD (vs. up 11.08% YTD a week ago) and the smaller-cap S&P Biotechnology Select Industry Index was up 20.38% YTD (vs. up 15.00% YTD a week ago). The Nasdaq Composite Index, closed up 4.04% YTD (vs. up 4.80% YTD a week ago). We have a new Contest leader! Holding 20% allocations in BLUE, CAPR and OMER, IMAN’s portfolio, up 51.53% YTD, vaulted into first place. GENE’s portfolio, up 48.86% YTD, moved back to second place and OHM’s portfolio, up 47.87% YTD, moved back to third place. At Friday's close, 49 of the 51 Contest portfolios were still in the black with a phenomenal 38 beating the NBI and 26 beating the SPSIBI. The 206 Contest stock picks have an average YTD gain of 17.61% Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None (All corrections, especially adjustments for buyouts & splits, greatly appreciated.) Have a safe & fun weekend biotechies! Peace & good health, Bulba 3/6/15 Rank Name Profit/Loss 1 IMAN 51,525 2 GENE 48,858 3 OHMS 47,874 4 MCBIO 46,241 5 OLIVIER 45,272 6 THEOX 39,776 7 DONS 37,080 8 BLADE 34,142 9 MOPGCW 33,657 10 GADGET 32,697 Week's Top 5 Gainers Symbol 2/27/15 3/6/15 Wk.%chg. DRRX 1.050 1.640 56.19% RGDO 1.150 1.600 39.13% CLDN 18.150 24.000 32.23% ADXS 9.000 11.900 32.22% CAPR 5.820 7.600 30.58% Week's Worst 5 Losers Symbol 2/27/15 3/6/15 Wk.%chg. SSH 5.750 4.030 -29.91% SUMM.L 183.000 141.500 -22.68% DARA 0.990 0.800 -19.19% SNMX 5.320 4.390 -17.48% OCRX 5.645 4.750 -15.85%